Ethereum Classic sees $37 rise amid DeeStream buzz

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

As ETC enjoys a $37 rise and DST hints at significant growth, XRP and LTC watchers eye market changes, signaling varied investor interest and market evolution.

Ethereum Classic (ETC) holders are experiencing a notable increase in value, with a $37 surge in the cryptocurrency’s price.

This comes as DeeStream (DST) enters the scene, speculated to offer significant returns. Meanwhile, Ripple (XRP) and Litecoin (LTC) enthusiasts are closely watching these developments, alongside other significant movements in the crypto market.

Ethereum Classic: Assessing risk and reward

Ethereum Classic has an average Investors Observer Risk/Reward score, meaning it has an average amount of risk in connection with the buying of this crypto.

However, looking at the 24-hour price, which decreased by -4.12%, with Ethereum Classic at $36.69, thus bringing the average risk in this kind of analysis due to high price volatility, with related changes in the volume of trade.

In this sense, the study has insightfully evaluated the manipulability and market dynamics of the coin for the investor.

Ripple: Divergent perspectives amid market trends

Ripple, meanwhile, offers quite different perspectives on market trends. According to CoinMarketCap statistics, Ripple’s 18% gain within a 30-day perspective is relatively modest.

However, other assets, such as BNB and Shiba Inu, produce serious surges. On the other side of the spectrum, crypto expert Mr. Huber has very different views from Panos Mekras, with Huber focusing on big news events or market shifts and saying that “you need technology and community to drive long-term growth.

Litecoin: Sentiment analysis and price levels

Litecoin receives a neutral sentiment rating from InvestorsObserver, with the cryptocurrency currently trading at $88.74—0.87% higher on the day versus a 1.44% increase in the broader market.

On the price front, the coin has support at $86.46 and resistance at $90.25, with a potential upside. Though Litecoin has been trading in recent sessions with weak volume, it scores quite well with the sentiment of both long and short-term investors.

DeeStream: Disrupting live streaming with blockchain

DeeStream is the upcoming disruptor in live streaming—an independent, blockchain-empowered platform.

The project aims to redefine how fans interact with the content and how monetization is made, reducing the risk of financial investment with frictionless sign-up and increasing shares of revenue for the content creator.

Interested investors will have an opportunity to purchase in stage one presale, where prices will start at a low of $0.04 with a base price value, resulting in maximum profits in their future and tokens in the future of decentralized live streaming.

Find out more about the DeeStream (DST) presale by visiting the website here.

Disclosure: This content is provided by a third party. does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.

Follow Us on Google News

The post Ethereum Classic sees $37 rise amid DeeStream buzz first appeared on


EU pulls back the curtain on organized crime, with 821 networks numbering 25,000 strong poisoning the economy |

Read More | Criminal networks in the European Union are penetrating legal businesses across the 27-nation bloc and rely heavily on corruption to develop their activities. That’s the bleak picture emerging from a report published Friday by the EU crime agency. Europol has identified 821 particularly threatening criminal networks with more than 25,000 members in […]

Tevogen Bio Holdings jumps after Nasdaq debut; announces $8M equity investment | AlphaStreet

Read More | Tevogen Bio Holdings Inc., (NASDAQ: TVGN), a clinical-stage specialty immunotherapy company, this week started trading on the Nasdaq stock market under the ticker symbol TVGN, after completing a business combination with Semper Paratus Acquisition Corporation. Tevogen is focused on developing off-the-shelf, genetically unmodified T-cell therapeutics in virology, oncology, and neurology. Soon after […]